Page 3 – The Fresh Toast

The President’s Inner Circle Stands on Marijuana

Terry Hacienda

-

April 6, 2026

The President’s Inner Circle Stands on Marijuana

The president’s Cabinet Cannabis Policy 2026: Where top officials stand on marijuana legalization, enforcement, and federal reform

As cannabis legalization expands across the United States, the stance of top federal officials remains a critical factor in determining the pace—and limits—of reform. With recent shakeups, what the President’s inner circle stands on marijuana? The economy is shakey and there is new leadership at the Department of Justice and Homeland Security, so now could be a could be a good time for a smart move. The industry is anxious as the administration’s approach to marijuana policy evolves in real time.

Vice President: JD Vance

Vice President Vance has taken a cautious but pragmatic tone on cannabis. While not an outspoken supporter of legalization, he has acknowledged the disconnect between federal law and state-level legalization. His approach leans toward states’ rights, suggesting tolerance rather than proactive reform.

Attorney General (Acting): Todd Blanche

As Acting Attorney General, Blanche steps into a pivotal role overseeing federal cannabis enforcement. While he has not built a public record on marijuana policy, acting leadership typically signals continuity. Expect a measured approach—maintaining current enforcement norms while avoiding sweeping changes on legalization or prosecution priorities.

Chief of Staff: Susie Wiles

Wiles remains a behind-the-scenes power player. While she has no public cannabis stance, her influence on policy prioritization and messaging is significant. She is expected to align cannabis positioning with broader political strategy rather than drive policy herself.

Senior Advisor: Stephen Miller

Miller continues to represent one of the more hardline voices in the administration. His broader emphasis on law enforcement and federal authority suggests skepticism toward legalization, particularly if framed as a public safety issue.

The Rise of the “Sober-ish” Guy — Official White House Photo by Andrea Hanks

Cabinet Secretaries

Secretary of State: Marco Rubio

Rubio has historically opposed recreational marijuana legalization, citing concerns about health and social impact. While he has softened slightly in support of medical research, he remains cautious about broader reform.

Secretary of the Treasury: Scott Bessent

Bessent’s role is central to cannabis banking reform and he has been holding his cards close to his chest. Though not publicly vocal, Treasury leadership will influence whether cannabis businesses gain broader access to financial services—a key issue for the industry.

Secretary of Defense: Pete Hegseth

Hegseth oversees a department where cannabis remains strictly prohibited. He has been active in the ongoing War on Drugs. There is little expectation of change, particularly given military readiness and federal drug policy standards.

Secretary of Health and Human Services: Robert F. Kennedy Jr.

Kennedy stands out as one of the most cannabis-friendly figures in the cabinet. He has supported legalization and regulation, framing marijuana as both a public health and criminal justice issue. His department could play a key role in rescheduling decisions.

Secretary of Homeland Security: Markwayne Mullin

Mullin brings a law-and-order perspective to DHS. His focus is expected to remain on illicit trafficking and border enforcement rather than state-legal cannabis markets. While not central to legalization debates, DHS under Mullin will influence how federal authorities handle interstate and cross-border cannabis issues.

Secretary of Commerce: Howard Lutnick

Lutnick is likely to view cannabis through an economic lens. As federal restrictions evolve, Commerce could play a role in normalization, especially regarding interstate trade and industry growth.

Secretary of Labor: Lori Chavez-DeRemer

Chavez-DeRemer has shown moderate openness on workforce-related cannabis issues, including employee protections and workplace policies tied to legalization.

Secretary of Energy: Chris Wright

Wright has not taken a clear public stance. However, cannabis cultivation’s energy use and environmental footprint could bring the issue into his policy orbit.

Secretary of Education: Linda McMahon

McMahon has expressed support for medical marijuana, noting its benefits in 2019. While she has not been directly linked to owning cannabis companies, her son, Shane McMahon, previously invested $500,000 in a Connecticut-based cannabis cultivation tech startup called EnviroGrow in 2015. The Federal educations programs under her are expected to continue focusing on prevention messaging.

Secretary of Veterans Affairs: Doug Collins

Collins has expressed openness to medical cannabis, particularly for veterans dealing with PTSD and chronic pain—an area of growing bipartisan interest.

Secretary of Agriculture: Brooke Rollins

Rollins’ focus leans more toward hemp than marijuana, but regulatory overlap keeps her relevant. She is expected to support agricultural innovation within federal limits.

Secretary of Transportation: Sean Duffy

Duffy has emphasized safety concerns, especially around impaired driving. His stance suggests a cautious, enforcement-oriented approach.

Secretary of Housing and Urban Development: Scott Turner

Turner has not prioritized cannabis policy publicly, though federal housing restrictions on marijuana use remain an ongoing issue.

Secretary of the Interior: Doug Burgum

Burgum brings a pragmatic perspective shaped by state-level legalization trends. His department could influence cannabis policy on federal lands and tribal jurisdictions.

With Todd Blanche now overseeing the Justice Department and Markwayne Mullin leading DHS, the administration’s cannabis policy appears to be entering a more transitional and enforcement-focused phase. The cabinet reflects a spectrum—from reform-friendly voices like Robert F. Kennedy Jr. to more cautious or skeptical figures like Marco Rubio and Stephen Miller. But all take their direction from the president.

For the cannabis industry and advocates, the takeaway is clear: federal reform is still possible, but it will likely come incrementally—shaped less by sweeping ideology and more by regulatory, economic, and political realities inside a shifting administration.

Marijuana At The End Of Life

Amy Hansen

-

April 6, 2026

0

As acceptance grows nationwide, marijuana at end-of-life care is reshaping comfort, dignity, and patient choice in final days.

Cannabis, long associated with counterculture and controversy, is increasingly being embraced in one of medicine’s most sensitive arenas: marijuana at end-of-life care. Across the United States, patients, families, and even traditionally cautious healthcare systems are reconsidering cannabis as a tool not just for treatment—but for comfort, dignity, and peace in life’s final chapter.

Hospice and palliative care focus on managing symptoms rather than curing disease, prioritizing quality of life for those facing terminal illness. In this setting, cannabis is gaining attention for its ability to address a wide range of physical and emotional challenges. Chronic pain, nausea, anxiety, insomnia, and loss of appetite are among the most common symptoms experienced by patients nearing the end of life, and studies suggest cannabis may help alleviate many of them.

What is particularly notable is the growing support among medical professionals. Surveys of hospice providers consistently show overwhelming approval of medical cannabis use in end-of-life care, with roughly 90 percent or more expressing support for its role in improving patient comfort. This marks a significant shift in a field which historically relied on powerful pharmaceuticals like opioids and sedatives—drugs which can dull pain but often leave patients heavily sedated and disconnected.

Cannabis, by contrast, is increasingly viewed as a complementary or alternative option which may allow patients to remain more alert and engaged. Some clinicians and caregivers report patients using cannabis are better able to interact with loved ones, enjoy food, and maintain a sense of presence during their final days. In a space where every moment matters, the distinction can be profound.

Even states traditionally slow to embrace marijuana reform are beginning to recognize its potential in this context. Louisiana, for example—long known for its cultural acceptance of alcohol but cautious approach to cannabis—has expanded its medical marijuana program in recent years. The inclusion of conditions related to severe and terminal illness reflects a broader shift: when it comes to end-of-life care, compassion often outweighs politics.

Still, barriers remain. Federal restrictions, inconsistent state laws, and a lack of standardized medical guidelines continue to limit access and create uncertainty for providers. Many hospice programs do not formally integrate cannabis into care plans, leaving patients and families to navigate its use independently. Yet demand continues to grow, driven largely by patients themselves.

At its core, the conversation around cannabis in end-of-life care is not just about medicine—it is about humanity. Dying is an intensely personal experience, and the goal of hospice is to make the transition as comfortable and meaningful as possible. For some, cannabis offers relief not only from physical pain but also from the emotional weight of facing mortality.

Equally important is the impact on loved ones. Watching a family member suffer through their final days can be deeply distressing. When patients are more comfortable, less anxious, and more present, it can transform the experience for those at the bedside. It allows for clearer conversations, shared moments, and a sense of peace often otherwise difficult to achieve.

As acceptance continues to grow, cannabis is emerging as more than an alternative therapy—it is becoming a compassionate option in the evolving landscape of end-of-life care, helping patients pass with greater comfort and giving families the gift of a more peaceful goodbye.

How Is The War Hitting The Cannabis Industry

Anthony Washington

-

April 2, 2026

0

How Is The War Hitting The Cannabis Industry

From Gas Prices to Weed – How the War in Iraq and Global Conflicts Are Rippling Through the Cannabis Market

Global conflict doesn’t stay confined to distant battlefields—it shows up quickly in everyday costs. From the gas pump to the grocery aisle to the price of a new car, war has a ripple effect across the entire economy. Energy markets are often the first to react. When supply is threatened or disrupted, oil prices surge, pushing gasoline costs higher for consumers and businesses alike. That increase feeds directly into transportation and production expenses, raising the price of nearly everything else. But how is the war hitting the cannabis industry?

Energy markets are typically the first to react to conflict, and the current situation is no exception. Oil supply concerns tied to Middle East instability have pushed fuel prices higher, raising the cost of gasoline nationwide. That surge doesn’t just affect drivers—it increases transportation and production costs across the economy. For cannabis businesses, which rely on shipping products within tightly regulated state markets, higher fuel costs are cutting directly into margins.

Food prices are also climbing under the weight of global instability. Wars disrupt farming, exports, and access to key agricultural inputs like fertilizer. While the Russia-Ukraine conflict initially drove much of this volatility, ongoing tensions linked to Iraq and the broader region are keeping supply chains strained. The result is persistent inflation at the grocery store, putting additional pressure on consumers who may already be cutting back on discretionary spending—including cannabis.

Meanwhile, the financial markets are reflecting this uncertainty. Volatility in major indices like the S&P 500 underscores how jittery investors have become. In times of instability, capital tends to retreat from emerging or heavily regulated industries. Cannabis, already facing federal uncertainty, often finds itself on the losing end of that shift, with funding becoming harder to secure.

Within the cannabis industry itself, these macroeconomic pressures are intensifying existing challenges. Indoor cultivation—still the dominant method in many states—requires significant electricity. As energy prices rise, so do the costs of growing cannabis. At the same time, supply chains for essentials like packaging, nutrients, and equipment are becoming more expensive and less reliable.

Consumers are beginning to notice. After years of falling prices driven by competition and oversupply, some markets are seeing stabilization or even modest increases. Discounts are shrinking, and premium products are inching higher in price, making affordability a growing concern for both recreational users and medical patients.

Compounding the issue is ongoing uncertainty at the federal level. The push to reschedule cannabis under the Drug Enforcement Administration has lost momentum as policymakers focus more heavily on international crises. Leadership shifts, including the exit of Pam Bondi, add another layer of unpredictability to an already murky regulatory landscape.

The result is a convergence of pressures: rising costs, constrained supply chains, cautious investment, and political distraction. As the War in Iraq and other global conflicts and tariffs continue to influence the broader economy, the cannabis market remains tightly tied to forces far beyond its control—feeling the impact from seed to sale.

What About Consuming Marijuana In Space

Anthony Washington

-

April 2, 2026

0

From zero gravity highs to lunar-grown cannabis, what about consuming marijuana in space as humanity expands beyond Earth?

With the launch of Artemis II, there is renewed public interest in outer space. But what about consuming marijuana in space. It’s a question that blends science, culture, and curiosity as humanity looks beyond our planet. With renewed interest in lunar missions and long-term space habitation led by organizations like NASA, the idea of marijuana in space or on the Moon is no longer purely science fiction—it’s a thought experiment with real implications.

First, consider the basics: space changes everything. Microgravity affects how flames burn, how liquids behave, and even how the human body processes substances. Smoking cannabis in space would be highly impractical, if not outright prohibited. Open flames are dangerous in controlled environments like spacecraft or lunar habitats, and air filtration systems would struggle with smoke particles. In short, lighting up a joint aboard a spacecraft is a non-starter.

But cannabis isn’t limited to smoking. Edibles, tinctures, and vaporized forms could theoretically be adapted for space use. Even then, the effects of THC on astronauts would need careful study. In microgravity, the body experiences fluid shifts toward the head, changes in blood circulation, and altered metabolism. Would a low-dose edible feel stronger in orbit? Would it impair already complex motor coordination tasks? These are not trivial questions when precision and safety are paramount.

Now imagine a future lunar base where long-term residents live and work. Cannabis could potentially play a role not just recreationally but therapeutically. Astronauts face isolation, stress, and disrupted sleep cycles. On Earth, cannabis is often used to manage anxiety, pain, and insomnia. Could it become part of a controlled wellness toolkit in space? Possibly—but only after rigorous testing and strict regulation.

Growing cannabis on the Moon presents another fascinating challenge. Plants have already been grown in space experiments aboard the International Space Station, proving that agriculture beyond Earth is possible. However, lunar conditions are extreme: reduced gravity, high radiation, and a lack of atmosphere. Cannabis, like any crop, would need to be cultivated in carefully controlled environments, likely alongside food crops. The question then becomes: is it worth the resources? Water, light, and space are limited commodities in a lunar habitat.

There’s also the legal dimension. Space law is still evolving, and cannabis laws vary widely even on Earth. Would a lunar colony follow U.S. federal law, international treaties, or develop its own regulatory framework? Until cannabis is uniformly legal at the federal level in the United States, it’s unlikely to be officially sanctioned in government-led missions.

Still, the cultural image is irresistible: a future where humanity gazes back at Earth from the Moon, perhaps with a carefully measured, lab-approved cannabis product in hand. It speaks to a broader truth—where humans go, their habits, curiosities, and coping mechanisms follow.

For now, marijuana in space remains speculative. But as missions expand and private companies join the race to establish off-world living, the conversation may shift from “what if” to “how.” And when that day comes, the intersection of cannabis and space will be less about novelty and more about science, safety, and the evolving human experience beyond Earth

WIth Pam Bondi Fired What’s Next For Marijuana

Terry Hacienda

-

April 2, 2026

0

Federal marijuana policy faces new uncertainty as leadership shakeup stalls rescheduling momentum and raises questions about enforcement direction.

The sudden firing of Pam Bondi has surprised his loyal followers. But with Pam Bondi fired what’s next for marijuana. It has injected new uncertainty into federal marijuana policy at a moment when long-promised reform was already moving at a cautious pace.

Bondi’s departure comes amid broader turmoil inside the administration of Donald Trump, with reports indicating frustration over unrelated Justice Department controversies ultimately led to her removal. But beyond the political drama, her exit could have real implications for cannabis policy—especially the long-anticipated federal rescheduling of marijuana.

At the time of her firing, marijuana remained in a transitional phase at the federal level. The administration had previously directed the Justice Department to move forward with rescheduling cannabis under federal law, a shift could ease research restrictions and reduce criminal penalties. However, the process had not yet been completed, leaving the industry, investors, and state regulators in limbo.

Bondi herself was not widely viewed as a champion of cannabis reform. During her earlier political career, she opposed marijuana legalization efforts, and even as attorney general, her role in rescheduling was seen more as executing White House directives than leading reform. The dynamic is important: federal cannabis policy under this administration has been driven less by the Justice Department and more by political calculations inside the White House.

Early reporting suggests Zeldin is a leading contender for the permanent role. Zeldin has historically taken a cautious stance on marijuana, opposing broad federal legalization while showing limited openness to medical use and states’ rights. His record suggests he may favor incremental changes over sweeping reform, leaving the pace of rescheduling uncertain.

Todd Blanche has little public record on marijuana policy, having built his career as a federal prosecutor and defense attorney focused on high-profile cases rather than drug reform. His approach is expected to align with broader Justice Department priorities rather than signal any independent push for cannabis legalization or rescheduling.

It appears Deputy Attorney General Todd Blanche may serve in an interim capacity. Zeldin is widely viewed as a loyalist aligned with Trump’s broader agenda, but he has not been closely associated with cannabis policy. The lack of a clear record creates uncertainty: he could accelerate rescheduling to claim a policy win, or slow-walk it depending on political priorities. He has little public record on marijuana policy, having built his career as a federal prosecutor and defense attorney focused on high-profile cases rather than drug reform.

The key issue is timing. Marijuana rescheduling is not automatic—it requires regulatory review, potential public comment, and coordination across agencies. A leadership change at the Justice Department can delay or redirect the process, especially if new leadership revisits legal strategy or enforcement priorities.

There is also a broader political context. The administration has signaled mixed messages on cannabis—supporting limited reform such as research expansion and CBD access while avoiding full federal legalization. That middle-ground approach leaves room for shifts depending on internal personnel and political pressures.

In practical terms, Bondi’s firing does not automatically change marijuana law. But it does introduce a pause—and potentially a pivot—at a critical moment. For the cannabis industry, state governments, and millions of consumers, the question is no longer just if federal policy will change, but how quickly and in what direction.

With a new attorney general likely to put their own stamp on the Justice Department, marijuana policy remains one of the most closely watched—and uncertain—issues in Washington.

Idaho Electeds At Odds With General Public On Cannabis

Terry Hacienda

-

March 31, 2026

0

Idaho Electeds At Odds With General Public On Cannabis

Idaho lawmakers escalate efforts to block cannabis legalization, restricting voter initiatives despite overwhelming public support.

Idaho electeds at odds with the general public on cannabis, joining the growing list of states where political leadership is increasingly at odds with shifting public opinion, particularly when it comes to marijuana policy. While much of the United States has moved toward legalization or at least decriminalization, Idaho remains one of the most resistant holdouts, with lawmakers continuing to take a hardline stance contrasting sharply with broader national trends.

While much of the country continues to liberalize cannabis laws, Idaho remains one of the strictest prohibition states in America, with no medical program, no decriminalization, and some of the harshest penalties in the nation. What makes Idaho stand out is not just resistance—but escalation.

In 2025, lawmakers took a dramatic step by advancing House Joint Resolution 4, a constitutional amendment designed to strip voters of their ability to legalize cannabis through ballot initiatives. If ultimately approved by voters, the measure would give exclusive authority over cannabis policy to the legislature itself, effectively ending citizen-led reform efforts permanently.

The push has clear political leadership. State Representative Bruce Skaug emerged as a central figure, sponsoring both the constitutional amendment and additional legislation imposing stricter penalties for cannabis possession. Support has also come from lawmakers like Senator Scott Grow, who argued elected officials—not voters—should control drug policy, emphasizing Idaho is “a democratic republic” rather than a direct democracy.

More recently, this month, Idaho lawmakers have gone even further. The state Senate passed a resolution explicitly urging residents not to sign a citizen-led petition to legalize medical cannabis—an extraordinary move critics say amounts to direct political interference in a democratic process. The resolution, championed by Senator Ben Toews, warned legalization would threaten Idaho’s “way of life” and tied cannabis reform to crime and social decline.

At the same time, lawmakers have continued introducing measures to tighten the initiative process itself, making it more difficult for grassroots campaigns to qualify for the ballot. These efforts coincide with a renewed push by advocacy groups to place the Idaho Medical Cannabis Act before voters in 2026—a proposal modeled conservatively and backed by strong public support.

The public support is not marginal. Polling has shown overwhelming backing for medical cannabis, with figures as high as 83% of likely voters in favor, including a strong majority of Republicans. Yet despite consensus, the legislature has consistently blocked or preempted reform.

Governor Brad Little has also reinforced the state’s hardline stance, previously stating voters “elected the wrong guy” if they expect legalization, underscoring the entrenched opposition at the highest levels of state government.

Critics argue Idaho has become a case study in political overreach—where lawmakers are not just resisting change, but actively working to prevent voters from having a voice. From constitutional amendments limiting ballot power to resolutions discouraging petition signatures, the state’s approach reflects a broader tension playing out nationwide: when public opinion shifts faster than those in power are willing to follow.

As the 2026 ballot effort moves forward, Idaho may soon face a defining question—not just about cannabis, but about who ultimately gets to decide.

Did Marijuana Play A Part In Cigarette Smokings HUGE Decline

Amy Hansen

-

March 31, 2026

0

Did marijuana play a part in cigarette smoking’s huge decline as U.S. adult rates fall below 10 percent?

The United States has achieved one of the most significant public health turnarounds in modern history: a dramatic and sustained decline in cigarette smoking. According to data published by the Centers for Disease Control and Prevention(CDC) and supported by peer-reviewed research in journals such as JAMA, adult smoking rates have fallen from more than 40 percent in the mid-1960s to 9.9% – a record low. This milestone reflects decades of coordinated scientific, regulatory, and cultural change. But did marijuana play a part in cigarette smokings HUGE decline.

To understand the magnitude of this shift, it is important to revisit the cultural landscape before 1964. Smoking was not just common—it was embedded in everyday life. People smoked on airplanes, in grocery stores, in offices, and even in hospitals. Cigarettes were advertised widely, including by physicians in some campaigns, and were often portrayed as symbols of sophistication and relaxation. This began to change when the Surge was released. The report definitively linked cigarette smoking to lung cancer and other serious diseases, marking a turning point in public awareness.

The scale of the decline is staggering. In 1965, roughly 42 percent of U.S. adults smoked. By 2000, the number had dropped significantly, and today it sits just under 10 percent. What was once ubiquitous—featured in movies, offices, and airplanes—is now increasingly rare in everyday life.

However, the story is not as simple as a straight-line victory. While cigarette use has plummeted, nicotine consumption has not disappeared. The rise of e-cigarettes and vaping has reshaped the landscape, particularly among younger adults. Public health experts remain divided: some view vaping as a harm-reduction tool helping smokers quit, while others warn it introduces a new generation to nicotine addiction.

This is where cannabis enters the conversation. As legalization spreads across the U.S., cannabis has increasingly been positioned—rightly or wrongly—as an alternative to tobacco. Some consumers report substituting cannabis for cigarettes, particularly in states where recreational use is legal. Additionally, the cultural normalization of cannabis has paralleled the denormalization of tobacco. Smoking a cigarette today often carries more stigma than consuming cannabis in many social circles.

There is also a behavioral shift at play. Modern consumers are more health-conscious and more willing to explore alternatives, whether it means vaping, nicotine pouches, or cannabis products. While cannabis is not risk-free, it is often perceived as less harmful than combustible tobacco, influencing consumer choices and potentially accelerating the decline in cigarette use.

Yet even as cigarette consumption drops, the tobacco industry remains highly profitable. Major tobacco companies have adapted rather than disappeared. They continue to generate billions in annual revenue, leveraging price increases, global markets, and new product categories like e-cigarettes and smokeless nicotine. Declining smoking rates in the U.S. have been offset by growth in developing markets and diversification into alternative nicotine products.

In other words, while fewer Americans are lighting up, the business of nicotine is far from extinguished. Tobacco companies are evolving alongside consumer behavior—ensuring even as traditional smoking declines, profitability endures.

The result is a paradox: a historic public health success unfolding alongside a resilient, highly profitable industry still shaping the future of consumption.

Waffle House And The Feds Keep Popping Up Together

Anthony Washington

-

March 30, 2026

0

Waffle House And The Feds Keep Popping Up Together

Smothered, Covered, and Government-Connected: Why Waffle House Keeps Showing Up in Federal Conversations.

Few American brands occupy the unusual intersection of culture, crisis response, and politics quite like Waffle House. Known for its round-the-clock service and no-frills menu, the Southern staple has become an unlikely but enduring touchpoint in government operations, political storytelling, and even viral controversy. But the Waffle House and the feds keep popping up together.

The latest example placing Waffle House back in the national spotlight involves Gregg Phillips, a senior leader connected to the Federal Emergency Management Agency. Phillips recently drew attention after remarks resurfaced in which he claimed he had been “teleported” to a Waffle House miles away from his original location. While the comments were made prior to his government role and dismissed by officials as personal, the story quickly spread across media and social platforms, raising questions about leadership credibility and further embedding Waffle House into the national conversation.

But long before viral headlines, Waffle House had already secured a legitimate and respected place within government disaster planning through the widely cited “Waffle House Index.” The term was coined by Craig Fugate, who led FEMA under Barack Obama. Fugate observed the chain’s ability to remain open—or quickly reopen—after severe weather events made it a reliable, real-time indicator of community impact. A full menu signals minimal damage, a limited menu indicates strain, and a closure suggests severe disruption.

This informal index has become a powerful shorthand in emergency management, reflecting the chain’s remarkable operational resilience. The resilience is no accident. In fact, Waffle House’s internal disaster response system has become a model studied by government agencies.

The company maintains highly organized “jump teams” deployed ahead of storms, bringing supplies, staff, and mobile resources into vulnerable areas. These teams are trained to operate under extreme conditions, often restoring service faster than utilities or infrastructure providers. As a result, Waffle House has been referenced in emergency management circles as a benchmark for corporate disaster response done right.

Government agencies, including FEMA, have looked to Waffle House’s playbook for insights into supply chain continuity, rapid reopening strategies, and decentralized decision-making. In an era where public-private partnerships are increasingly critical during disasters, the chain represents a rare example of a private company influencing how government thinks about resilience and recovery.

The connection between Waffle House and government also extends into politics and personal narrative. Nancy Mace has frequently cited her experience working at the restaurant as foundational to her worldview. Her story—moving from service industry work to Congress—has been used to highlight themes of economic mobility and the value of hard work, reinforcing the brand’s symbolic role in American life.

Beyond formal policy and politics, Waffle House also plays an informal role in public service culture. Its 24/7 operations make it a gathering place for law enforcement, first responders, and shift workers, further embedding it into the fabric of civic life.

Taken together, these threads reveal a uniquely American story. Waffle House is more than a restaurant—it is a cultural institution, a disaster response bellwether, a training model for resilience, and now, occasionally, a backdrop for political headlines.

Whether serving hash browns during a hurricane or appearing in viral government controversies, Waffle House continues to demonstrate even the most unassuming institutions can hold a significant place at the intersection of business and government.

Is Cannabis The New Coffee For Focus And Burnout Relief

Sarah Johns

-

March 27, 2026

0

Is Cannabis The New Coffee For Focus And Burnout Relief

Professionals are turning to cannabis microdosing for work as a calmer, more controlled alternative to caffeine and stress.

For decades, coffee has been the unofficial fuel of the workplace—powering early mornings, long meetings, and tight deadlines. But a growing number of professionals are beginning to rethink the ritual. In its place, a new trend is emerging: microdosing for work. Rather than seeking a high, users are turning to low, controlled doses of marijuana to improve focus, reduce anxiety, and manage burnout throughout the day. So is cannabis the new coffee for focus and burnout relief?

Microdosing typically involves consuming very small amounts of cannabis, often just enough to feel subtle effects without impairment. For many, this means low-dose THC products, balanced THC and CBD blends, or CBD-dominant options. The goal is not to escape work, but to engage with it more calmly and clearly.

This shift is being driven in part by changing attitudes toward both cannabis and workplace wellness. As legalization expands and stigma declines, more professionals—especially those in high-pressure, creative, or tech-driven roles—are experimenting with alternatives to traditional stimulants. While caffeine can boost alertness, it can also increase jitters, anxiety, and energy crashes. Cannabis, when used in small amounts, is being explored as a smoother, more sustainable option.

Advocates of cannabis microdosing for work say it can take the edge off stress without dulling productivity. Some report improved concentration, enhanced creativity, and better emotional regulation during demanding tasks or meetings. Others find it helpful for navigating long workdays without the peaks and crashes associated with multiple cups of coffee.

However, the effects of cannabis are highly individualized, and the margin between a productive dose and an impairing one can be narrow. Factors such as body chemistry, tolerance, and the specific product used all play a role. A dose which helps one person focus may leave another feeling distracted or fatigued. This variability is one reason why experts emphasize starting low and adjusting gradually.

There are also practical and legal considerations. Cannabis remains restricted in many workplaces, and policies can vary widely depending on location and industry. Even in regions where cannabis is legal, using it during work hours may conflict with company rules or professional expectations. For some, microdosing is limited to remote work environments or specific creative tasks where flexibility is greater.

Health professionals also caution while early anecdotal reports are promising, more research is needed to fully understand cannabis’s effects on cognition and productivity. Regular use, even at low doses, may impact tolerance, memory, or motivation over time.

Still, the rise of cannabis microdosing for work reflects a broader shift in how people approach performance and well-being. Instead of pushing through stress with ever-increasing amounts of caffeine, many are looking for ways to stay balanced, focused, and mentally resilient. As this trend continues to evolve, it raises important questions about the future of workplace habits—and what it really means to be productive.

Cannabis And The Different Ways You Sleep

Amy Hansen

-

March 27, 2026

0

Cannabis And The Different Ways You Sleep

Cannabis and how you consume can influence sleep quality, morning energy, and productivity.

As cannabis continues to move into the wellness mainstream, most conversations focus on how it makes you feel in the moment—relaxed, creative, sleepy, or social. One of the ways people have embraced the green plant is to help with sleep. Roughly 1 in 3 people struggle to get a sound snooze at night. While known as a sleep aide, you need to know about cannabis and the different ways you sleep. It can subtly shape how you feel when you wake up, influencing everything from mental clarity to mood and productivity.

For some, the experience is positive. A low-dose edible or a few puffs before bed can ease anxiety and help users fall asleep faster, leading to what feels like a deeper, more restorative night. These individuals often report waking up refreshed, with reduced stress and improved focus. But for others, the story is more complicated.

Tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis, interacts with the body’s endocannabinoid system in ways affecting sleep cycles—particularly REM sleep, the stage associated with dreaming and cognitive restoration. While THC may help users fall asleep more quickly, some research suggests it can reduce time spent in REM sleep. The result can be a night feeling long but may not deliver the same level of mental recovery, leaving some users feeling groggy or mentally foggy the next morning.

The method of consumption also plays a major role. Edibles, which are metabolized through the liver, tend to produce longer-lasting effects than inhaled cannabis. This means a dose taken in the evening can still be active in the body well into the next morning. This lingering presence can contribute to what some users describe as a mild “hangover” effect—characterized by sluggishness, dry mouth, or difficulty concentrating.

Timing and dosage are equally important. Higher doses of THC, especially taken late at night, are more likely to produce next-day side effects. In contrast, lower doses or products including cannabidiol (CBD) may offer a more balanced experience. CBD is non-intoxicating and is often associated with calming effects without the same level of cognitive impairment, making it a popular option for those looking to avoid morning grogginess.

Individual differences also matter. Metabolism, tolerance, and even personality traits can influence how cannabis affects the body overnight. Some users find small adjustments—such as consuming cannabis earlier in the evening, reducing dosage, or choosing different product formulations—can significantly improve how they feel the next day.

As cannabis use becomes more normalized among professionals and wellness-minded consumers, understanding next-day effects is increasingly important. Whether you are using cannabis to unwind, improve sleep, or manage stress, paying attention to how you feel the following morning can offer valuable insight. In many cases, optimizing cannabis use is less about what you feel at night and more about how you function the day after.

The Fresh ToastThe most trusted name in cannabis

The president’s Cabinet Cannabis Policy 2026: Where top officials stand on marijuana legalization, enforcement, and federal reform

Vice President: JD Vance

Attorney General (Acting): Todd Blanche

Chief of Staff: Susie Wiles

Senior Advisor: Stephen Miller

Cabinet Secretaries

Secretary of State: Marco Rubio

Secretary of the Treasury: Scott Bessent

Secretary of Defense: Pete Hegseth

Secretary of Health and Human Services: Robert F. Kennedy Jr.

Secretary of Homeland Security: Markwayne Mullin

Secretary of Commerce: Howard Lutnick

Secretary of Labor: Lori Chavez-DeRemer

Secretary of Energy: Chris Wright

Secretary of Education: Linda McMahon

Secretary of Veterans Affairs: Doug Collins

Secretary of Agriculture: Brooke Rollins

Secretary of Transportation: Sean Duffy

Secretary of Housing and Urban Development: Scott Turner

Secretary of the Interior: Doug Burgum

As acceptance grows nationwide, marijuana at end-of-life care is reshaping comfort, dignity, and patient choice in final days.

From Gas Prices to Weed – How the War in Iraq and Global Conflicts Are Rippling Through the Cannabis Market

From zero gravity highs to lunar-grown cannabis, what about consuming marijuana in space as humanity expands beyond Earth?

Federal marijuana policy faces new uncertainty as leadership shakeup stalls rescheduling momentum and raises questions about enforcement direction.

Idaho lawmakers escalate efforts to block cannabis legalization, restricting voter initiatives despite overwhelming public support.

Did marijuana play a part in cigarette smoking’s huge decline as U.S. adult rates fall below 10 percent?

Smothered, Covered, and Government-Connected: Why Waffle House Keeps Showing Up in Federal Conversations.

Professionals are turning to cannabis microdosing for work as a calmer, more controlled alternative to caffeine and stress.

Cannabis and how you consume can influence sleep quality, morning energy, and productivity.

Don't Miss Your Weekly Dose of The Fresh Toast.